CLOMIPRAMINE HYDROCHLORIDE
What it is
We have not added a short description yet.
Why it is on this page
People: patients with Obsessive-Compulsive Disorder whose obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning (DSM-III-R); labeled effectiveness data include adults and children and adolescents 10 to 17 years of age
DailyMed clomipramine (Anafranil) label · checked Oct 16, 2026
Relationship: labeled indication
Statement scope
- Formulation or format
capsule
- Indication
treatment of obsessions and compulsions in Obsessive-Compulsive Disorder (OCD)
- Labeler
SpecGx LLC
- Population
patients with Obsessive-Compulsive Disorder whose obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning (DSM-III-R); labeled effectiveness data include adults and children and adolescents 10 to 17 years of age
- Product
ANAFRANIL (clomipramine hydrochloride) capsule
- Section code
34067-9
Source collection coverage: country:US
Pointer: /sections/0
Supporting passage: Anafranil ™ (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).
Open sourceSource: DailyMed clomipramine (Anafranil) label. Checked Oct 16, 2026. Scope: country:US. Link: https://dailymed.nlm.nih.gov/dailymed/services/v2/spls/4074b555-7635-41a9-809d-fae3b3610059.xml
Research for Obsessive-Compulsive Disorder
Not reviewed
No current published assessment exists for this exact Treatment and Need. This does not establish benefit or no benefit.
Compared with the others: Not directly compared. We show each option’s own research.